For immediate release |
14 February 2012 |
Spectra Systems Corporation
("Spectra" or the "Company")
Appointment of Non-Executive Director
Spectra, a leading provider of advanced technology solutions for banknote and product authentication, is pleased to announce that on 13 February 2012 Jeffrey Donohue joined the Company as a Non-Executive director, replacing Mark Curcio, whose resignation as a Non-Executive director was announced on 10 February 2012.
Jeffrey Peter Donohue (aged 40) is Corporate Counsel for Novartis Institutes for BioMedical Research, Inc. ("NIBRI"), the research arm of the global healthcare products company Novartis. Mr. Donohue provides legal guidance on NIBRI's strategic acquisitions, licensing agreements, academic and government-backed consortia, and drug discovery collaborations. Mr. Donohue also is an Adjunct Professor at Boston University School of Law, USA, where he teaches advanced courses on licensing and intellectual property transactions.
Before joining NIBRI, Mr. Donohue served as Corporate Counsel at Vertex Pharmaceuticals Incorporated, a pharmaceutical company based in Cambridge, Massachusetts, USA. Mr. Donohue started his legal career at Kirkpatrick & Lockhart LLP (now K&L Gates), where he spent seven years advising clients on corporate governance, mergers and acquisitions, and securities matters. Mr. Donohue obtained his Juris Doctor from Boston University and a B.A. from Brandeis University.
Mr. Donohue was also a director of Raise The Sky Inc., from March 2009 until August 2010. There is no further information that is required to be disclosed in relation to Mr. Donohue pursuant to Schedule 2(g) of the AIM Rules for Companies.
Commenting on the appointment, Dr. Nabil Lawandy, Chief Executive of Spectra, said: "Jeff is a timely addition to the Spectra Board of Directors as we explore potential acquisitions and implement the next phase of our growth strategy."
Enquiries:
Spectra Systems Corporation
Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700
WH Ireland Limited
Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650
Media Enquires:
The Communications Portfolio Limited
Ariane Comstive / Caolan Mahon Tel: +44 (0) 20 7536 2028 / 2029
ariane.comstive@communications-portfolio.co.uk
- Ends -